Navigation Links
Accera, Inc. to Present at Upcoming Investor Conferences
Date:3/25/2009

BROOMFIELD, Colo., March 25 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) disorders, today announced that the company will be participating at two upcoming healthcare investor conferences.

Dr. Steve Orndorff, Founder, President and CEO, will speak at the 2nd Annual BIO Venture Conference on April 1 at 10:15 a.m. EDT at the Sheraton Boston Hotel in Boston, MA. On April 9 at 11:30 a.m. PDT, he will present at the C21 BioVentures Conference at the Meritage Resort in Napa Valley, CA.

In early March, the company launched Axona(TM), a medical food available only by prescription for mild-to-moderate Alzheimer's disease. Dr. Orndorff will provide an overview of Accera and its technology pipeline and also provide an update on the successful nationwide launch of Axona.

About Accera, Inc.

Accera, Inc., a privately held biotechnology company, discovers and develops product breakthroughs in treating central nervous system disorders. Accera's novel therapeutic approaches positively impact patients with neurodegenerative disorders, who are in need of effective, well-tolerated treatments. Through its proprietary scientific platform, Accera is developing therapies that address metabolic deficiencies by providing an alternative energy source to the brain.

About Axona(TM)

Axona is a first-in-class medical food for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer's disease. Dispensed by prescription, Axona targets the metabolic deficiencies and imbalances associated with Alzheimer's disease by providing an alternative energy source for brain cells. With simple administration and once-a-day convenience, Axona is complementary to current Alzheimer's disease therapies.

    Contacts:
    Media:                                  Investors:
'/>"/>
SOURCE Accera, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Accera, Inc. to Present at the 4th Annual BIO Investor Forum
2. Accera, Inc. Names William T. Poncy Vice President of Commercial Development
3. Accera, Inc. Completes $35 Million Series C Financing
4. Accera, Inc. Sponsors Alzheimers Associations 2009 ICAD Conference
5. Dr. Thomas Werner Elected to Accera, Inc.s Board of Directors
6. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
7. Avicena Group to Present at Noble Financial Conference
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CEL-SCI to Present at the Noble Financial Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory ... services, today announced that the Company has been informed ... Hong Kong listed company and a ... agreement (the "Agreement") to purchase the Company,s outstanding 7% ...
(Date:5/4/2015)... Marianjoy Rehabilitation Hospital ... and hand impairments by acquiring the Armeo®Spring arm ... network site. , Secured through grant support of ... treatment option for patients with upper extremity weakness ... one of just four Illinois providers offering treatment ...
(Date:5/1/2015)... May 1, 2015 /CNW/ - Softchoice, a leading North American IT ... the proud recipient of two Cisco® Partner Summit Country awards. ... the Year and Security Partner of the Year for ... place this week in Montreal . ... two Cisco partner awards at this year,s conference," said ...
(Date:5/1/2015)... RESEARCH TRIANGLE PARK, N.C. , May 1, 2015 /PRNewswire/ ... Roger Jeffs , Ph.D., President and Co-Chief Executive Officer ... the company,s business at the Deutsche Bank 40 th ... . The presentation will take place on Wednesday, ... be accessed via a live webcast on the United Therapeutics ...
Breaking Biology Technology:China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 2China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 3Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2Softchoice recognized with two Country Awards at Cisco Partner Summit 2015 2
... Rochelle, NY, October 3, 2008Novel platform technologies and key ... molecular diagnostics, reports Genetic Engineering and Biotechnology News ... can be significant as Kalorama Information predicts that this ... $5.4 billion in four years, according to an article ...
... LOUISVILLE, Colo., Oct. 3 Sound Surgical Technologies,LLC, ... internationally,renowned ultrasonic scientist Mark Schafer, Ph.D. as the ... and Development., "Dr. Schafer is a welcome ... Dan Goldberger. "His unrivaled knowledge in the field ...
... Inc. (Amex: ADL ), a leading vertically integrated ... today announced that the,Company will present at the Maxim ... October 7, 2008 at 10:30 a.m. ET. AMDL,s presentation,will ... in the Morosco Room., The Maxim Group Growth ...
Cached Biology Technology:Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics 2Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development 2AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 2AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 3
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) has ... - NEC" report to their offering. ... to supply a range of IT security management and ... on the development of a Big Data and cloud ... Asia-Pacific region is a core ...
(Date:4/2/2015)... BETHESDA, Md. , April 2, 2015 ... Salt Lake City , the American ... election of five new directors to its Board.  Members ... for the ACMG and for forming and advancing its ... the medical genetics profession. "It,s an eventful ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... be up to three feet long in humans -- keep ... projections on neurons, are made stronger by a unique modification ... The finding, which may help guide the search for treatments ... of Neuron by researchers at the University of ...
... have been expressed about possible health risks from high intake ... exist to routinely eliminate excess levels of the vitamin, and ... No level of vitamin E in the diet or ... according to an expert from the Linus Pauling Institute at ...
... dialysis derive long-term benefit from the minimally invasive placement ... access grafts, according to 12-month trial results being presented ... Meeting in New Orleans. "Results of the study ... dialysis patients," said Ziv J Haskal, M.D., FSIR, lead ...
Cached Biology News:Scientists learn what makes nerve cells so strong 2Excess vitamin E intake not a health concern 2Stenting dramatically improves treatment access for dialysis patients 2Stenting dramatically improves treatment access for dialysis patients 3
... and finishing services are tailored to ... large-scale 5' screening or full length ... experience with large-scale genome projects and ... ideal cDNA outsourcing solution. In addition, ...
... Agencourt offers quick turnaround sequencing of individual ... and high copy plasmids. Agencourt's world-class, high ... Phred20 bases per day. The key ... service are 24 48 hour sample ...
Great for biotinylating DNA/RNA probes...
...
Biology Products: